Alliance Pharma (LON:APH) Hits New 52-Week High – Here’s What Happened

Alliance Pharma plc (LON:APHGet Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 61.50 ($0.75) and last traded at GBX 61.20 ($0.75), with a volume of 4399260 shares traded. The stock had previously closed at GBX 61.10 ($0.75).

Alliance Pharma Price Performance

The stock has a market cap of £330.83 million, a P/E ratio of -1,020.00, a price-to-earnings-growth ratio of 1.04 and a beta of 0.67. The company has a debt-to-equity ratio of 47.46, a quick ratio of 1.42 and a current ratio of 2.93. The firm has a 50-day moving average price of GBX 47.08 and a 200-day moving average price of GBX 42.40.

About Alliance Pharma

(Get Free Report)

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.

Read More

Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.